Panel Votes Against Medtronic’s Chronicle, Offers Ideas For New Trial
This article was originally published in The Gray Sheet
Executive Summary
FDA's Circulatory System Devices Panel offered Medtronic advice on how to design a new trial for its Chronicle implantable hemodymanic monitor after voting against approval of the product's PMA